论文部分内容阅读
本文报导24小时内发病的急性脑梗死患者用激素治疗的结果。本组共53例,26例用地塞美松27例未用。诊断系根据神经系统检查、脑脊液检查、同位素脑扫描、脑超声检查、头颅照片和脑血管造影,个别病例作了尸检。住院后,属于激素治疗组者立即给与地塞美松4毫克,每六小时一次,于12天后逐步减量。每例在住院当天第8、15、22、29天分别观察意识状态、运动障碍、感觉缺损、失语、偏盲、颅神经麻痹和凝视麻痹等体征变化。用激素组与未用激素组的平均年龄、病损分布和意识障碍程度均相似。53例中有31例为嗜睡或木僵,7例昏迷。从第一日至第29日生存病例的神经系统缺损,其好转的百分率激素组为35.6%±25.8%,对照组为16.7%±22.4%,说明用激素组的患者较对照组的患者结局好。未用激素组有5例死亡,内
This article reports the results of hormone therapy in patients with acute cerebral infarction within 24 hours of onset. A total of 53 patients in this group, 26 cases of sememectam 27 cases unused. The diagnosis was based on neurological examination, cerebrospinal fluid examination, isotope brain scan, brain ultrasound, cranial photographs and cerebral angiography, individual cases were autopsy. After hospitalization, those who belong to the hormone treatment group were given dexamethasone 4 mg once every six hours, gradually reducing after 12 days. Each patient was observed on the 8th, 15th, 22th and 29th day of hospitalization for changes of signs such as consciousness status, dyskinesia, sensory loss, aphasia, hemianopia, cranial nerve paralysis and gaze paralysis. The average age, distribution of lesions and levels of disturbance of consciousness in both hormone-treated and untreated groups were similar. Among the 53 cases, 31 were drowsiness or stupor, and 7 were unconscious. From the first day to the 29th day survival cases of nervous system defects, the improvement of the percentage of hormone group was 35.6% ± 25.8%, control group was 16.7% ± 22.4%, indicating that patients with hormones than the control group patients with good outcome . In the unused hormone group there were 5 deaths within